← Back to Search

Behavioral Intervention

Contingency Management for Alcoholism

N/A
Waitlist Available
Led By Michael McDonell, PhD
Research Sponsored by Washington State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Self reported American Indian/Alaskan Native
Current alcohol dependence
Timeline
Screening 3 weeks
Treatment Varies
Follow Up twice weekly for twelve weeks
Awards & highlights

Study Summary

This study examines the impact of a culturally tailored version of contingency management treatment on alcohol in 400 alcohol dependent American Indians and Alaskan Natives. Participants will be recruited from addiction treatment agencies and throughout the community. Those who complete a 4 week induction period will be randomized to receive 12 weeks of contingency management or a non-contingent control condition. Individuals will then be followed for an additional 3-months to assess the long term efficacy of the treatment.

Eligible Conditions
  • Alcoholism

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check β€œYes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~twice weekly for twelve weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and twice weekly for twelve weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in alcohol use as assessed by ethyl glucuronide detection in urine

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Contingency ManagementExperimental Treatment1 Intervention
Group II: Non-Contingent Control GroupActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Contingency Management
2003
Completed Phase 2
~3220

Find a Location

Who is running the clinical trial?

Washington State UniversityLead Sponsor
100 Previous Clinical Trials
56,074 Total Patients Enrolled
7 Trials studying Alcoholism
1,091 Patients Enrolled for Alcoholism
Michael McDonell, PhDPrincipal InvestigatorWashington State University
2 Previous Clinical Trials
323 Total Patients Enrolled
2 Trials studying Alcoholism
323 Patients Enrolled for Alcoholism

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~38 spots leftby Mar 2025